middle.news
Imagion Biosystems Secures $3.5M to Advance HER2+ Breast Cancer Trial
9:44am on Monday 4th of August, 2025 AEST
•
Healthcare
Read Story
Imagion Biosystems Secures $3.5M to Advance HER2+ Breast Cancer Trial
9:44am on Monday 4th of August, 2025 AEST
Key Points
A$3.5 million capital raised via two-tranche placement led by CPS Capital
Funds to support Phase 2 HER2+ Breast Cancer clinical trial in the USA
Placement includes free attaching listed options exercisable at $0.04
Directors to subscribe for $150,000 in shares pending shareholder approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imagion Biosystems (ASX:IBX)
OPEN ARTICLE